the authors studied the effect of anaprilin monotherapy ( dose : 160-200 mg/daily for 10 months ) on the level of atherogenic apolipoproteins ( apo a , apo b ) and fractions of plasma cholesterol in 34 patients with ischemic heart disease , stable exertion angina pectoris ( class 2-3 ) .
C0003591
apolipoproteins
C0003592
apo a